Increased GCNT1 expression has already been linked to PCa progression, shown to increase prostate tumour growth in vivo, and been implicated in synthesis of the cancer-associated SLeX antigen (Chen et al., 2014, Hagisawa et al., 2005, Kojima et al., 2015). The gene discussed is GCNT1; the disease is posterior cortical atrophy.